Cargando…

Potential therapeutic strategy for non-Hodgkin lymphoma by anti-CD20scFvFc/CD28/CD3zeta gene tranfected T cells

BACKGROUND: Anti-CD20 monoclonal antibody treatment has not only increased survival and cure rates in many non-Hodgkin lymphomas, but also has prompted an explosion in the development of novel antibodies and biologically active substances with specific cellular targets in the field of malignancies t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zheng, Yihu, Yu, Kang, Du, Jimei, Jiang, Lei, Zhang, Shenghui, Han, Yixiang, Yu, Panpan, Tan, Yingxia
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2939546/ https://www.ncbi.nlm.nih.gov/pubmed/20815894 http://dx.doi.org/10.1186/1756-9966-29-121

Ejemplares similares

T cell stimulation and expansion by SunTag-based clustering of anti-CD3/CD28 scFv
por: Zhong, Kunhong, et al.
Publicado: (2020)

Gene transfer of Hodgkin cell lines via multivalent anti-CD30 scFv displaying bacteriophage
por: Chung, Yoon-Suk A, et al.
Publicado: (2008)

Identification of Potent CD19 scFv for CAR T Cells through scFv Screening with NK/T-Cell Line
por: Kang, Chung Hyo, et al.
Publicado: (2020)

Increase of CD3(+)CD7(−) T cells in bone marrow predicts invasion in patients with T-cell non-Hodgkin’s lymphoma
por: Huang, Ziyang, et al.
Publicado: (2022)

Targeting scFv-Fc-scTRAIL fusion proteins to tumor cells
por: Hutt, Meike, et al.
Publicado: (2018)

Biological Evaluation of (131)I- and CF750-Labeled Dmab(scFv)-Fc Antibodies for Xenograft Imaging of CD25-Positive Tumors
por: Fan, Qing, et al.
Publicado: (2014)

Isolation and characterization of human anti-CD20 single-chain variable fragment (scFv) from a Naive human scFv library
por: Shams, Nasir, et al.
Publicado: (2022)

Malignant B Cells Induce the Conversion of CD4(+)CD25(−) T Cells to Regulatory T Cells in B-Cell Non-Hodgkin Lymphoma
por: Han, Yixiang, et al.
Publicado: (2011)

Generation of 1E8 Single Chain Fv-Fc Construct Against Human CD59
por: Hong, Jeong-Won, et al.
Publicado: (2012)

CD40-directed scFv-TRAIL fusion proteins induce CD40-restricted tumor cell death and activate dendritic cells
por: El-Mesery, M, et al.
Publicado: (2013)

Minimizing leukemia escape: implementing a dual anti-CD20- and CD19-scFv-based chimeric antigen receptor (CAR)
por: Schneider, Dina, et al.
Publicado: (2015)

The CD3 zeta cytoplasmic domain mediates CD2-induced T cell activation
Publicado: (1992)

Development of Human-Like scFv-Fc Neutralizing Botulinum Neurotoxin E
por: Miethe, Sebastian, et al.
Publicado: (2015)

Design, Characterization, and Evaluation of scFvCD133/rGelonin: A CD133-Targeting Recombinant Immunotoxin for Use in Combination with Photochemical Internalization
por: Olsen, Cathrine Elisabeth, et al.
Publicado: (2019)

An anti-CD30 single-chain Fv selected by phage display and fused to Pseudomonas exotoxin A (Ki-4(scFv)-ETÁ) is a potent immunotoxin against a Hodgkin-derived cell line
por: Klimka, A, et al.
Publicado: (1999)

Generation of functional scFv intrabody to abate the expression of CD147 surface molecule of 293A cells
por: Tragoolpua, Khajornsak, et al.
Publicado: (2008)

The Development of a Recombinant scFv Monoclonal Antibody Targeting Canine CD20 for Use in Comparative Medicine
por: Jain, Saurabh, et al.
Publicado: (2016)

Expression Optimization of Anti-CD22 scFv-Apoptin Fusion Protein Using Experimental Design Methodology
por: Amiri, Solmaz Agha, et al.
Publicado: (2018)

Characterization of thymus-derived lymphocytes expressing Ti alpha-beta CD3 gamma delta epsilon zeta-zeta, Ti alpha-beta CD3 gamma delta epsilon eta-eta or Ti alpha-beta CD3 gamma delta epsilon zeta-zeta/zeta- eta antigen receptor isoforms: analysis by gene transfection
Publicado: (1990)

CD28(−) and CD28(low)CD8(+) Regulatory T Cells: Of Mice and Men
por: Vuddamalay, Yirajen, et al.
Publicado: (2017)

CD70-restricted specific activation of TRAILR1 or TRAILR2 using scFv-targeted TRAIL mutants
por: Trebing, J, et al.
Publicado: (2014)

A novel anti-CD22 scFv–apoptin fusion protein induces apoptosis in malignant B-cells
por: Agha Amiri, Solmaz, et al.
Publicado: (2017)

Development of an antibody-ligand fusion protein scFvCD16A(-)sc4-1BBL in Komagataella phaffii with stimulatory activity for Natural Killer cells
por: Li, Yangyang, et al.
Publicado: (2023)

Targeting CEA in Pancreas Cancer Xenografts with a Mutated scFv-Fc Antibody Fragment
por: Girgis, Mark D, et al.
Publicado: (2011)

Cre-mediated cellular modification for establishing producer CHO cells of recombinant scFv-Fc
por: Kawabe, Yoshinori, et al.
Publicado: (2015)

Development of human-like scFv-Fc antibodies neutralizing Botulinum toxin serotype B
por: Rasetti-Escargueil, Christine, et al.
Publicado: (2015)

Evaluation of METase-pemetrexed-loaded PEG–PLGA nanoparticles modified with anti-CD133–scFV for treatment of gastric carcinoma
por: Xin, Lin, et al.
Publicado: (2018)

Development of a Novel Anti-CD19 CAR Containing a Fully Human scFv and Three Costimulatory Domains
por: Wutti-in, Yupanun, et al.
Publicado: (2022)

T cell receptor complexes containing Fc epsilon RI gamma homodimers in lieu of CD3 zeta and CD3 eta components: a novel isoform expressed on large granular lymphocytes
Publicado: (1992)

A CD19-Anti-ErbB2 scFv Engager Protein Enables CD19-Specific CAR T Cells to Eradicate ErbB2(+) Solid Cancer
por: Hombach, Andreas A., et al.
Publicado: (2023)

CD28 engagement inhibits CD73-mediated regulatory activity of CD8(+) T cells
por: Lai, Yo-Ping, et al.
Publicado: (2021)

CD3(+)CD8(+)CD28(−) T Lymphocytes in Patients with Lupus Nephritis
por: Żabińska, Marcelina, et al.
Publicado: (2016)

Generation of Anti-Idiotype scFv for Pharmacokinetic Measurement in Lymphoma Patients Treated with Chimera Anti-CD22 Antibody SM03
por: Zhao, Qi, et al.
Publicado: (2014)

Unique binding modes for the broad neutralizing activity of single-chain variable fragments (scFv) targeting CD4-induced epitopes
por: Tanaka, Kazuki, et al.
Publicado: (2017)

Correction: Evaluation of METase-pemetrexed-loaded PEG-PLGA nanoparticles modified with anti-CD133-scFV for treatment of gastric carcinoma
Publicado: (2020)

Prognostic significance of peripheral CD8+CD28+ and CD8+CD28− T cells in advanced non-small cell lung cancer patients treated with chemo(radio)therapy
por: Liu, Chao, et al.
Publicado: (2019)

The CD28-Transmembrane Domain Mediates Chimeric Antigen Receptor Heterodimerization With CD28
por: Muller, Yannick D., et al.
Publicado: (2021)

Lymphoplasmacytic non-Hodgkin lymphoma/Waldenström's macroglobulinemia with CD5+, CD23+, and CD10-
por: D'Angelo, Guido, et al.
Publicado: (2013)

CD4-Binding Site Directed Cross-Neutralizing scFv Monoclonals from HIV-1 Subtype C Infected Indian Children
por: Kumar, Sanjeev, et al.
Publicado: (2017)

Development of a novel human phage display-derived anti-LAG3 scFv antibody targeting CD8(+) T lymphocyte exhaustion
por: Ascione, Alessandro, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_kq9f034jte2bq0k69hgogas80m